Why the study?
Does the AGTR1 gene polymorphism affect the clinical presentation of arterial hypertension and its association with metabolic syndrome?
Does the AGTR1 gene polymorphism affect the clinical presentation of arterial hypertension and its association with metabolic syndrome?
The C allele of the AGTR1 gene is associated with a distinct clinical profile in arterial hypertension, including synchronous development with metabolic syndrome.
Hypothesis-generating for AGTR1 polymorphism in hypertension subtypes; larger studies needed before clinical relevance.
According to the literature, arterial hypertension is a multifactorial disease with a significant genetic component; therefore, the study of pathogenic mechanisms of this disease depending on gene polymorphism of the angiotensin system, in particular AGTR1, is of special interest. This study involved 30 patients, in 15 of whom arterial hypertension was diagnosed as a component of metabolic syndrome while the remaining 15 ones had isolated arterial hypertension. The genotyping of patients was performed using the polymerase chain reaction and detection of amplification products by horizontal agarose gel electrophoresis. DNA was extracted from blood samples. All patients underwent 24-hour BP monitoring (ABPM). Two groups were formed according to the results of PCR: one consisted of patients with the AGTR1А1166А genotype (n=16) and the other included patients with the AGTR1А1166СorAGTR1С1166С genotypes (n=14). The groups were matched for age, sex, body-weight index (BWI), and waist circumference (WC). We studied the features of arterial hypertension, the clinical course including duration of AH, maximum and minimum values of systolic and diastolic blood pressure during 24 hours, the degree of night-time drop in BP, and effects of antihypertensive therapy. It was shown that systolic blood pressure, duration of the disease, comorbidity, effects of the treatment, the frequency of metabolic syndrome were significantly different in the two groups. It was concluded that hypertension and metabolic syndrome may develop synchronously in patients with the C allele of the AGTR1 gene.
No takes yet. Share an insight, caveat, or question.
Зотова et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: